Mustang Bio Inc (NASDAQ: MBIO) Pronounces The Encouraging MB-106 Safety And Efficacy Data

The stock of Mustang Bio Inc (NASDAQ: MBIO) dropped to $3.76. An Associate Professor known as Dr. Shadman has presented the updated MB-106 safety and efficacy data, a move that targets helping patients struggling with two serious conditions. The first one happens to be chronic lymphocytic leukemia (“CLL”) and the other […]